Effects of ethanol in a putative rodent model of tardive dyskinesia

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 3, 1996, Pages 541-546

  Stoessl, A Jon ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Alcohol; GABA; Neuroleptics; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ALCOHOL; BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; FLUPHENAZINE; NEUROLEPTIC AGENT;

ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXTRAPYRAMIDAL SYSTEM; GABAERGIC SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MASTICATION; NONHUMAN; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA;

ANIMALIA; RODENTIA;

EID: 0029992855     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02208-2     Document Type: Article

References (63)

1. 2 receptor binding. J. Neural Transm. 79:215-226; 1990.
2. Bonetti, E. P.; Burkhard, W. P.; Gabi, M.; Hunkeler, W.; Lorez, H. P.; Martin, J. R.; Moehler, H.; Osterrieder, W.; Pieri, L.; Polc, P.; Richards, J. G. Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol. Pharmacol. Biochem. Behav. 31:733-749; 1989.
3. Buck, K. J.; Hahner, L.; Sikela, J.; Harris, R. A. Chronic ethanol treatment alters brain levels of γ-aminobutyric acidA receptor subunit mRNAs: Relationship to genetic differences in ethanol withdrawal seizure severity. J. Neurochem. 57:1452-1455; 1991.
4. Burt, D. R.; Creese, I.; Snyder, S. H. Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science 196:326-328; 1977.
5. Cardoso, F.; Jankovic, J. Movement disorders. Neurol. Clin. 11:625-638; 1993.
6. Diana, M.; Collu, M.; Mura, A.; Gessa, G. L. Haloperidol-induced vacuous chewing in rats: Suppression by α-methyltyrosine. Eur. J. Pharmacol. 211:415-419; 1992.
7. Dixon, L.; Weiden, P. J.; Sweeney, J.; Frances, A. J. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Comp. Psychiatry 33:121-122; 1992.
8. 2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse 18:178-189; 1994.
9. Fahn, S. Treatment of tardive dyskinesia: Use of dopamine-depleting agents. Clin. Neuropharmacol. 6:151-158; 1983.
10. Ferguson, J. N.; Egan, M. F.; Bachus, S. E.; Hyde, T. M.; Wyatt, R. J.; Grega, D.; Kleinman, J. E. Reduced striatonigral activity related to vacuous chewing movements induced by acute haloperidol treatment: A possible model for dystonia. Soc. Neurosci. Abstr. 20:1262; 1994.
11. Fibiger, H. C.; Lloyd, K. G. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis. Trends Neurosci. 7:462-464; 1984.
12. Fornazzari, L.; Carlen, P. L. Transient choreiform dyskinesias during alcohol withdrawal. Can. J. Neurol. Sci. 9:89-90; 1982.
13. Gao, X. M.; Kakigi, T.; Friedman, M. B.; Tamminga, C. A. Tiagabine inhibits haloperidol-induced oral dyskinesias in rats. J. Neural Transm. 95:63-69; 1994.
14. Grant, K. A. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5:383-404; 1994.
15. Gunne, L. M.; Haggstrom, J. E. Reductions of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology (Berlin) 81:191-194; 1983.
16. Gunne, L.-M.; Haggstrom, J.-E.; Sjoquist, B. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309:347-349; 1984.
17. Gunne, L. M.; Andersson, U.; Bondesson, U.; Johansson, P. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25:897-901; 1986.
18. Halliday, J. Dyskinesia and withdrawal from alcohol. Br. J. Psychiatry 165:409-410; 1994.
19. Harris, C. M.; Lal, H. Central nervous system effects of the imidazodiazepine Ro 15-4513. Drug Dev. Res. 13:187-203; 1988.
20. Hashimoto, T.; Yanagisawa, N. Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue). J. Neurol. Sci. 100:178-185; 1990.
21. 35S]butylbicyclophosphorothionate. Neurochem. Int. 16:187-191; 1990.
22. Iversen, S. D.; Howells, R. B.; Hughes, R. P. Behavioral consequences of long-term treatment with neuroleptic drugs. Adv. Biochem. Psychopharmacol. 24:305-313; 1980.
23. Jackson, H. C.; Nutt, D. J. Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice. Eur. J. Pharmacol. 221:199-203; 1992.
24. Jicha, G. A.; Salamone, J. D. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to Parkinsonian symptoms. J. Neurosci. 11:3822-3829; 1991.
25. Kane, J. M.; Smith, J. M. Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch. Gen. Psychiatry 39:473-481; 1982.
26. Kaneda, H.; Shirakawa, O.; Dale, J.; Goodman, L.; Bachus, S.; Tamminga, C. A. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. Eur. J. Pharmacol. 212:43-49; 1992.
27. Kazamatsuri, H.; Chien, C.-P.; Cole, J. O. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch. Gen. Psychiatry 27:95-99; 1972.
28. Kojima, T.; Yamauchi, T.; Miyasaka, M.; Koshino, Y.; Nakane, Y.; Takahashi, R.; Shimazono, Y.; Yagi, G. Treatment of tardive dyskinesia with ceruletide - A double-blind, placebo-controlled study. Psychiatr. Res. 43:129-136; 1992.
29. Koller, W. C.; Biari, N. Effect of alcohol on tremors: Comparison with propranolol. Neurology 34:221-222; 1984.
30. 3H]-spiperone binding sites in postmortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J. Neural Transm. 75:1-10; 1989.
31. Korpi, E. R. Role of GABAA receptors in the actions of alcohol and in alcoholism: Recent advances. Alcohol Alcohol. 29:115-129; 1994.
32. Lai, H.; Carino, M. A.; Horita, A. Effects of ethanol on central dopamine function. Life Sci. 27:299-304; 1980.
33. Liljequist, S. Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration. Acta Pharmacol. Toxicol. 43:19-28; 1978.
34. Lucey, J. V.; Dinan, T. G. Orofacial dyskinesia and the alcohol dependence syndrome. Psychol. Med. 22:79-83; 1992.
35. Lutz, E. G. Neuroleptic-induced akathisia and dystonia triggered by alcohol. JAMA 236:2422-2423; 1976.
36. Mhatre, M. C.; Ticku, M. K. Chronic ethanol administration alters γ-aminobutyric acidA receptor gene expression. Mol. Pharmacol. 42:415-422; 1992.
37. A receptor α-subunit mRNAs in the rat cerebral cortex. Mol. Pharmacol. 39:157-163; 1991.
38. - uptake in cerebral cortical synaptoneurosomes. J. Pharmacol. Exp. Ther. 246:158-164; 1988.
39. A receptor function and expression in brain. Alcohol 7:237-244; 1990.
40. Mullin, P. J.; Kershaw, P. W.; Bolt, J. M. W. Choreoathetotic movement disorder in alcoholism. Br. Med. J. 4:278-281; 1970.
41. Neiman, J.; Lang, A. E.; Fornazzari, L.; Carlen, P. L. Movement disorders in alcoholism: A review. Neurology 40:741-746; 1990.
42. Nutt, D. J.; Peters, T. J. Alcohol: The drug Br. Med. Bull. 50: 5-17; 1994.
43. Peris, J.; Coleman-Hardee, M.; Burry, J.; Pecins-Thompson, M. Selective changes in GABAergic transmission in substantia nigra and superior colliculus caused by ethanol and ethanol withdrawal. Alcohol. Clin. Exp. Res. 16:311-319; 1992.
44. Prunell, M.; Escorihuela, R. M.; Fernandez-Teruel, A.; Nunez, J. F.; Tobena, A. Differential interactions between ethanol and Ro 15-4513 on two anxiety tests in rats. Pharmacol. Biochem. Behav. 47:147-151; 1994.
45. - currents in neurons of the chick, rat, and mouse central nervous system. Eur. J. Pharmacol. 224:173-181; 1992.
46. 1 dopamine receptor-activated c-fos. Brain Res. 523:288-290; 1990.
47. 1 stimulation. Life Sci. 33: 2479-2482; 1983.
48. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Cholinergic manipulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology (Berlin) 79:226-230; 1983.
49. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology (Berlin) 85:71-79; 1985.
50. 35S]butylbicyclophosphorothionate: A biochemical tool to study the pharmacology of ethanol at the γ-aminobutyric acid-coupled chloride channel. J. Pharmacol. Exp. Ther. 256:922-927; 1991.
51. Seiler, N.; Graufel, C.; Elands, J.; Vandenbuuse, M.; Knodgen, B.; Sarhan, S.; Moran, P.; Gobaille, S. Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin. Pharmacol. Biochem. Behav. 50:181-189; 1995.
52. Singh, L.; Lewis, A. S.; Field, M. J.; Hughes, J.; Woodruff, G. N. Evidence for an involvement of the brain cholecystokinin β receptor in anxiety. Proc. Natl. Acad. Sci. USA 88:1130-1133; 1991.
53. Steinpreis, R. E.; Baskin, P.; Salamone, J. D. Vacuous jaw movements induced by subchronic administration of haloperidol: Interactions with scopolamine. Psychopharmacology (Berlin) 111:99-105; 1993.
54. 2 receptor antagonists. Psychopharmacology (Berlin) 98:372-379; 1989.
55. Stoessl, A. J.; Polanski, E. Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy. Neuropharmacology 32:555-560; 1993.
56. Suzdak, P. D.; Glowa, J. R.; Crawley, J. N.; Schwartz, R. D.; Skolnick, P.; Paul, S. M. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 234:1243-1247; 1986.
57. Tamminga, C. A.; Thaker, G. K. GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effect on mental status. Drug Dev. Res. 21:227-233; 1990.
58. Tarsy, D.; Baldessarini, R. J. Pharmacologically induced behavioral supersensitivity to apomorphine. Nat. New Biol. 245:262-263; 1973.
59. Thaker, G. K.; Tamminga, C. A.; Alphs, L. D.; Lafferman, J.; Ferraro, T. N.; Hare, T. A. Brain γ-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Arch. Gen. Psychiatry 44:522-529; 1987.
60. Torres, G. Acute administration of alcohol blocks cocaine-induced striatal c-fos immunoreactivity protein in the rat. Synapse 18:161-167; 1994.
61. Waddington, J. L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berlin) 101:431-447; 1990.
62. Waddington, J. L.; Cross, A. J.; Gamble, S. J.; Bourne, R. C. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530-532; 1983.
63. Waddington, J. L.; Molloy, A. G. The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: Tardive dyskinesia or dystonia? Psychopharmacology (Berlin) 91:136-137; 1987.